Updated content in: 17/12/2023

Reaching the zero malaria target

Although malaria is both preventable and treatable, it continues to have devastating health effects around the world. In its sixteenth year of commemoration, the Malaria Day in the Americas 2022 provides an opportunity for countries in the Americas to encourage the participation of all actors and stakeholders with the theme "Reaching Zero Malaria" in the fight against the disease. Urgent and concentrated actions must be taken to ensure the adoption of measures that allow investments and innovations in new approaches to control, diagnosis, drug treatments and other tools and instruments that resolve and dynamize the commitment to the fight against malaria. (PAHO/WHO)

Vaccines against malaria

RTS,S/AS01 (RTS,S) is the first and, to date, the only vaccine to show that it can significantly reduce malaria, and life-threatening severe malaria, in young African children. It acts against P. falciparum, the most deadly malaria parasite globally and the most prevalent in Africa. Among children who received 4 doses in large-scale clinical trials, the vaccine prevented approximately 4 in 10 cases of malaria over a 4-year period. (PAHO/WHO)


Documents on VHL

Malaria and Covid-19

In the face of a dual threat of antimalarial drug resistance and COVID-19, countries of the Greater Mekong subregion have also made major strides towards their shared goal of elimination by 2030. In the 6 countries of the subregion, the reported number of malaria cases fell by 97% between 2000 and 2020. Malaria deaths were reduced by more than 99% in the same period of time. (PAHO/WHO)


Documents on VHL